Publications by authors named "Yichang Su"

Claim this Profile
T
Toxicological assessment of novel Anti-COVID traditional Chinese medicine formulae NRICM101 and NRICM102: a comprehensive study on safety and genotoxicity.
Chun-Tang Chiou, Chao-Lin Chang, Yu-Hwei Tseng, Geng-You Liao, Jiunn-Wang Liao, Yi-Chang Su

Front Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response letter to the comment on "Utilization of home-based traditional Chinese medicine in a homebound population under the Integrated Home-Based Medical Care program in Taiwan".
Wen-Chiung Chang, Yi-Chang Su

J Formos Med Assoc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of home-based traditional Chinese medicine in a homebound population under the integrated home-based medical care program in Taiwan.
Wen-Chiung Chang, Yi-Chang Su

J Formos Med Assoc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of NRICM101 for COVID-19 in Taiwan: A cross-sectional survey.
Yu-Hwei Tseng, Yu-Ching Huang, Chia-Ching Liaw, Yi-Chang Su

J Formos Med Assoc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic protective effects of TCM formula NRICM102 and -acetylcysteine against hepatorenal injury in a mouse model of bongkrekic acid poisoning.
Yuh-Chiang Shen, Yea-Hwey Wang, Kuo-Tong Liou, Wen-Chi Wei, Jing-Jy Cheng, Yi-Chang Su

Front Pharmacol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRICM101 in combatting COVID-19 induced brain fog: Neuroprotective effects and neurovascular integrity preservation in hACE2 mice.
Cher-Chia Chang, Yea-Hwey Wang, Jiin-Cherng Yen, Chia-Ching Liaw, Keng-Chang Tsai, Yi-Chang Su

J Tradit Complement Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pre- and post-course survey of an elective Chinese medicine curriculum among junior Western medical students in Taiwan.
Sunny Jui-Shan Lin, Shung-Tai Ho, Yi-Chang Su, Chien-Sung Tsai, Shu-Meng Cheng

BMC Complement Med Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A quick method to customize pictorial blood assessment tools towards better measurement: Method development and validation.
Chien-Ming Chen, Yu-Hwei Tseng, Sunny Jui-Shan Lin, Li-Li Chen, Jun-Dai Lin, Yi-Chang Su

Taiwan J Obstet Gynecol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations and guidelines of integrative medicine for COVID-19 care: The APEC project outcome.
Libin Jia, Michelle Beidelschies, Joel M Evans, Richard C Niemtzow, Songxuan Zhou Niemtzow, Yi-Chang Su, Hiroshi Yotsuyanagi

Integr Med Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Traditional Chinese medicine in the treatment of patients with hyperuricemia: A randomized placebo-controlled double-blinded clinical trial.
Pui-Ying Leong, Huang-Hsi Chen, Shuo-Yan Gau, Chia-Yin Chen, Yi-Chang Su

Int J Rheum Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of traditional Chinese medicine body constitution and all-cause mortality in patients with type 2 diabetes mellitus: a prospective cohort study of a Taiwanese medical center.
Cheng-Hung Lee, Yi-Chang Su, Shih-Yi Lin, I-Te Lee, Chia-I Tsai

Front Med (Lausanne)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between traditional Chinese medicine body constitution deviation and chronic pelvic pain: A cross-sectional study.
Chien-Ming Chen, Sunny Jui-Shan Lin, Yun-Ning Tsai, Yi-Chang Su, I-Hsin Chen

Taiwan J Obstet Gynecol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development and application of NRICM101 and NRICM102 for the treatment of COVID-19.
Shung-Tai Ho, Yun-Ning Tsai, Yi-Chang Su

J Formos Med Assoc· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRICM101 ameliorates SARS-CoV-2-S1-induced pulmonary injury in K18-hACE2 mice model.
Wen-Chi Wei, Keng-Chang Tsai, Chia-Ching Liaw, Chun-Tang Chiou, Yu-Hwei Tseng, Yi-Chang Su

Front Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy analysis and research progress of complementary and alternative medicines in the adjuvant treatment of COVID-19.
Jaung-Geng Lin, Guan-Jhong Huang, Yi-Chang Su

J Biomed Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Use and Discontinuation of Traditional Chinese Herbal Medicine and Dietary Supplements in Taiwan: A Cross-Sectional Questionnaire Survey.
Te-Chun Yeh, Shung-Tai Ho, Che-Hao Hsu, Ju-O Wang, Senyeong Kao, Yi-Chang Su, Sunny Jui-Shan Lin

Healthcare (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Traditional Chinese medicine body constitution predicts new-onset diabetic albuminuria in patients with type 2 diabetes: Taichung diabetic body constitution prospective cohort study.
Cheng-Hung Lee, Chia-I Tsai, Yi-Chang Su, Shih-Yi Lin, I-Te Lee

Medicine (Baltimore)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating COVID-19 with NRICM101 and NRICM102 - Author's reply 2.
Ming-Yung Lee, Yu-Hwei Tseng, Sunny Jui-Shan Lin, Yi-Chang Su

Pharmacol Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating COVID-19 with NRICM101 and NRICM102 - Author's reply.
Sunny Jui-Shan Lin, Ming-Yung Lee, Yu-Hwei Tseng, Yi-Chang Su

Pharmacol Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating COVID-19 with NRICM101 and NRICM102 - Author's reply 3.
Yu-Hwei Tseng, Sunny Jui-Shan Lin, Ming-Yung Lee, Yi-Chang Su

Pharmacol Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levonorgestrel intrauterine devices improve body constitution deviations in the perspective of traditional Chinese medicine and quality of life in patients with chronic pelvic pain and heavy menstrual bleeding.
Chien-Ming Chen, Yun-Ning Tsai, Chien-Hsiun Chen, Yu-Hwei Tseng, Sunny Jui-Shan Lin, Yi-Chang Su

Taiwan J Obstet Gynecol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curbing COVID-19 progression and mortality with traditional Chinese medicine among hospitalized patients with COVID-19: A propensity score-matched analysis.
Yu-Hwei Tseng, Sunny Jui-Shan Lin, Sheng-Mou Hou, Chih-Hung Wang, Shun-Ping Cheng, Tsung-Lung Tsai, Wei-Chen Hsu, Yi-Chang Su

Pharmacol Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis.
Wen-Chi Wei, Chia-Ching Liaw, Keng-Chang Tsai, Chun-Tang Chiou, Yu-Hwei Tseng, Chen-Sung Lin, Yi-Chang Su

Pharmacol Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101).
Yi-Chang Su, Guan-Jhong Huang, Jaung-Geng Lin

Front Pharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study.
Keng-Chang Tsai, Yi-Chia Huang, Chia-Ching Liaw, Chia-I Tsai, Chun-Tang Chiou, Sunny Jui-Shan Lin, Yi-Chang Su

Biomed Pharmacother· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis